Details of the Drug Formulaction

General Information of Drug Formulation (ID: F07804)

• Formulation Name: Everolimus 0.25 mg tablet
• Company: Novartis Pharmaceuticals Corporation

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Everolimus	(DM8X2EH)	Advanced cancer	2A00-2F9Z	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Butylated hydroxytoluene	(E00336)	31404	Antioxidant
Crospovidone	(E00626)	Not Available	Disintegrant
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant